vs
科睿唯安（CLVT）与因美纳（ILMN）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是科睿唯安的1.9倍（$1.1B vs $585.5M），因美纳净利率更高（12.3% vs -6.9%，领先19.1%），因美纳同比增速更快（4.8% vs -1.4%），因美纳自由现金流更多（$251.0M vs $78.9M），过去两年因美纳的营收复合增速更高（-1.3% vs -5.1%）
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
CLVT vs ILMN — 直观对比
营收规模更大
ILMN
是对方的1.9倍
$585.5M
营收增速更快
ILMN
高出6.2%
-1.4%
净利率更高
ILMN
高出19.1%
-6.9%
自由现金流更多
ILMN
多$172.1M
$78.9M
两年增速更快
ILMN
近两年复合增速
-5.1%
损益表 — Q1 FY2026 vs Q1 FY2027
| 指标 | | |
|---|---|---|
| 营收 | $585.5M | $1.1B |
| 净利润 | $-40.2M | $134.0M |
| 毛利率 | 67.2% | 66.1% |
| 营业利润率 | 5.2% | 19.2% |
| 净利率 | -6.9% | 12.3% |
| 营收同比 | -1.4% | 4.8% |
| 净利润同比 | 61.3% | — |
| 每股收益（稀释后） | $-0.06 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLVTILMN
| Q1 26 | $585.5M | $1.1B | ||
| Q4 25 | $617.0M | $1.2B | ||
| Q3 25 | $623.1M | — | ||
| Q2 25 | $621.4M | — | ||
| Q1 25 | $593.7M | — | ||
| Q4 24 | $663.0M | $1.1B | ||
| Q3 24 | $622.2M | $1.1B | ||
| Q2 24 | $650.3M | $1.1B |
净利润CLVTILMN
| Q1 26 | $-40.2M | $134.0M | ||
| Q4 25 | $3.1M | $334.0M | ||
| Q3 25 | $-28.3M | — | ||
| Q2 25 | $-72.0M | — | ||
| Q1 25 | $-103.9M | — | ||
| Q4 24 | $-191.8M | $186.0M | ||
| Q3 24 | $-65.6M | $705.0M | ||
| Q2 24 | $-304.3M | $-2.0B |
毛利率CLVTILMN
| Q1 26 | 67.2% | 66.1% | ||
| Q4 25 | 66.8% | 65.5% | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | 65.9% | ||
| Q3 24 | 66.2% | 69.0% | ||
| Q2 24 | 67.2% | 64.8% |
营业利润率CLVTILMN
| Q1 26 | 5.2% | 19.2% | ||
| Q4 25 | 6.7% | 17.4% | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | -3.5% | — | ||
| Q4 24 | -9.4% | 15.8% | ||
| Q3 24 | 3.5% | 68.6% | ||
| Q2 24 | -36.9% | -147.2% |
净利率CLVTILMN
| Q1 26 | -6.9% | 12.3% | ||
| Q4 25 | 0.5% | 28.8% | ||
| Q3 25 | -4.5% | — | ||
| Q2 25 | -11.6% | — | ||
| Q1 25 | -17.5% | — | ||
| Q4 24 | -28.9% | 16.8% | ||
| Q3 24 | -10.5% | 65.3% | ||
| Q2 24 | -46.8% | -178.8% |
每股收益（稀释后）CLVTILMN
| Q1 26 | $-0.06 | $0.87 | ||
| Q4 25 | $0.00 | $2.16 | ||
| Q3 25 | $-0.04 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-0.27 | $1.16 | ||
| Q3 24 | $-0.09 | $4.42 | ||
| Q2 24 | $-0.46 | $-12.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.2B |
| 总债务越低越好 | $4.3B | — |
| 股东权益账面价值 | $4.8B | $2.7B |
| 总资产 | $10.9B | $6.6B |
| 负债/权益比越低杠杆越低 | 0.89× | — |
8季度趋势，按日历期对齐
现金及短期投资CLVTILMN
| Q1 26 | — | $1.2B | ||
| Q4 25 | $329.2M | $1.6B | ||
| Q3 25 | $318.7M | — | ||
| Q2 25 | $362.6M | — | ||
| Q1 25 | $354.0M | — | ||
| Q4 24 | $295.2M | $93.0M | ||
| Q3 24 | $388.5M | $70.0M | ||
| Q2 24 | $376.4M | $74.0M |
总债务CLVTILMN
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
股东权益CLVTILMN
| Q1 26 | $4.8B | $2.7B | ||
| Q4 25 | $4.8B | $2.7B | ||
| Q3 25 | $4.9B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $5.0B | — | ||
| Q4 24 | $5.1B | $2.4B | ||
| Q3 24 | $5.5B | $2.1B | ||
| Q2 24 | $5.6B | $1.4B |
总资产CLVTILMN
| Q1 26 | $10.9B | $6.6B | ||
| Q4 25 | $11.1B | $6.6B | ||
| Q3 25 | $11.2B | — | ||
| Q2 25 | $11.4B | — | ||
| Q1 25 | $11.5B | — | ||
| Q4 24 | $11.5B | $6.3B | ||
| Q3 24 | $12.0B | $6.0B | ||
| Q2 24 | $12.1B | $6.1B |
负债/权益比CLVTILMN
| Q1 26 | 0.89× | — | ||
| Q4 25 | 0.89× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $134.7M | $289.0M |
| 自由现金流经营现金流 - 资本支出 | $78.9M | $251.0M |
| 自由现金流率自由现金流/营收 | 13.5% | 23.0% |
| 资本支出强度资本支出/营收 | 9.5% | — |
| 现金转化率经营现金流/净利润 | — | 2.16× |
| 过去12个月自由现金流最近4个季度 | $333.9M | $1.1B |
8季度趋势，按日历期对齐
经营现金流CLVTILMN
| Q1 26 | $134.7M | $289.0M | ||
| Q4 25 | $159.9M | $321.0M | ||
| Q3 25 | $181.1M | — | ||
| Q2 25 | $116.3M | — | ||
| Q1 25 | $171.2M | — | ||
| Q4 24 | $141.3M | $364.0M | ||
| Q3 24 | $202.9M | $316.0M | ||
| Q2 24 | $126.2M | $80.0M |
自由现金流CLVTILMN
| Q1 26 | $78.9M | $251.0M | ||
| Q4 25 | $89.2M | $267.0M | ||
| Q3 25 | $115.5M | — | ||
| Q2 25 | $50.3M | — | ||
| Q1 25 | $110.3M | — | ||
| Q4 24 | $59.1M | $335.0M | ||
| Q3 24 | $126.3M | $284.0M | ||
| Q2 24 | $60.3M | $49.0M |
自由现金流率CLVTILMN
| Q1 26 | 13.5% | 23.0% | ||
| Q4 25 | 14.5% | 23.0% | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 8.9% | 30.3% | ||
| Q3 24 | 20.3% | 26.3% | ||
| Q2 24 | 9.3% | 4.4% |
资本支出强度CLVTILMN
| Q1 26 | 9.5% | — | ||
| Q4 25 | 11.5% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 12.4% | 2.6% | ||
| Q3 24 | 12.3% | 3.0% | ||
| Q2 24 | 10.1% | 2.8% |
现金转化率CLVTILMN
| Q1 26 | — | 2.16× | ||
| Q4 25 | 51.58× | 0.96× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Subscription | $397.5M | 68% |
| Re-occurring | $108.6M | 19% |
| Transactional | $79.4M | 14% |
ILMN
| Product revenue | $917.0M | 84% |
| Service and other revenue | $174.0M | 16% |
